{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:45Z","timestamp":1793406765686,"version":"4.5.0"},"reference-count":271,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.3109\/10428194.2016.1173212","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T02:53:41Z","timestamp":1461812021000},"page":"1991-2013","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets"],"prefix":"10.3109","volume":"57","author":[{"given":"Agata M.","family":"Bogusz","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"e_1_3_2_2_1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et\u00a0al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008."},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.792112"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.04.002"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1625"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1639"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3306"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092882"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-555722"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902763509"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0785"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.09010.x"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-3105"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2879"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.139"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02146.x"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200106089"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm076"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.21997"},{"key":"e_1_3_2_22_1","first-page":"24","article-title":"ATM mutations in B-cell chronic lymphocytic leukemia.","volume":"59","author":"Bullrich F","year":"1999","unstructured":"Bullrich F, Rasio D, Kitada S, et\u00a0al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 1999;59:24\u201327.","journal-title":"Cancer Res"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-395673"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0838"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7872"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.08.023"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.8762"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-224071"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1630"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-154070"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401499"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403242"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25497"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14666"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1032"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.019"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10113"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109016"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110921"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2584"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-429282"},{"key":"e_1_3_2_43_1","article-title":"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.","author":"Jeromin S","year":"2013","unstructured":"Jeromin S, Weissmann S, Haferlach C, et\u00a0al. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia. 2013;28:108\u2013117.","journal-title":"Leukemia"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488197"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-458265"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373159"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.357"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-546150"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534271"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-490847"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-433540"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539726"},{"key":"e_1_3_2_53_1","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia.","author":"Nadeu F","year":"2016","unstructured":"Nadeu F, Delgado J, Royo C, et\u00a0al. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia. Blood. 2016. [Epub ahead of print]. pii: blood-2015-07-659144.","journal-title":"Blood"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-543306"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386144"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.060129"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.239"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038158"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.263"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1402716"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0104"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1674"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23313"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.3260"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.7577"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.214"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711053171904"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23958"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1333"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.8190"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-355255"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.08.003"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e3283513fb2"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07528.x"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/00313021003631296"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.02.004"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3937.bloodjournal88103937"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2132"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571786"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361972"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.75"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140616"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2460"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.266"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.900759"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.035"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10351"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.518"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457283"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028585"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11606"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09730"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2856"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3018"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.8.2289.2289"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.013359"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036277"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08582.x"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2230"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03194.x"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1226.1226"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-475954"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-118794"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0015"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-452284"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1997.tb04519.x"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPIVKZRMPF93ET"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03042.x"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821ddaec"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2726.2726"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010568"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(99)00034-X"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20907"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0034"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039859"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-142182"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61272"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010264"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.141"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.039"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093401"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3419"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.44"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.008474"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314608110"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-391474"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478834"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510441103"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517177"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28321"},{"key":"e_1_3_2_138_1","first-page":"8:1280\u20131288","article-title":"A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.","author":"Kanduri M","year":"2013","unstructured":"Kanduri M, Sander B, Ntoufa S, et\u00a0al. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics. 2013;8:1280\u20131288.","journal-title":"Epigenetics"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep01400"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.09.003"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.0410"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-370122"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pap.0000184176.65919.17"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2005.04.013"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06389.x"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.008"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3701"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.070458"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404314"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.8.2996"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2003.10.014"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00526-X"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403369"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005488"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436329"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.62"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP10ZCLFZGYZIP"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-525808"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-550905"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564583"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation.V2012.1.426.3798535"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.031146"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.58"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008202303666"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870040213"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.11.3601"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03571-6"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/523170"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000051"},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.6150"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2665"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-267476"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07176.x"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083244"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400635"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203033"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-264275"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-359166"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120904"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.365"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120910"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.330"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014209"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08868.x"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.054874"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08963.x"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-368209"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371179"},{"key":"e_1_3_2_191_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPL0OPXI9LZITV"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2012.11.005"},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPQLQ89VXTVWKN"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPDN4Q1JTFGCFC"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-513523"},{"key":"e_1_3_2_196_1","first-page":"513049","article-title":"BRAF V600E-Negative Hairy Cell Leukaemia.","volume":"2013","author":"Langabeer SE","year":"2013","unstructured":"Langabeer SE, O\u2019Brien D, McElligott AM, et\u00a0al. BRAF V600E-Negative Hairy Cell Leukaemia. Case Rep Hematol. 2013;2013:513049.","journal-title":"Case Rep Hematol"},{"key":"e_1_3_2_197_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12735"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008004"},{"key":"e_1_3_2_199_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0093"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1118-3"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031425"},{"key":"e_1_3_2_203_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-2"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2986"},{"key":"e_1_3_2_205_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-279083"},{"key":"e_1_3_2_206_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-430140"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-543793"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09837"},{"key":"e_1_3_2_209_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-412981"},{"key":"e_1_3_2_210_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0014"},{"key":"e_1_3_2_211_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-643361"},{"key":"e_1_3_2_212_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.565435"},{"key":"e_1_3_2_213_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-201731"},{"key":"e_1_3_2_214_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-379339"},{"key":"e_1_3_2_215_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2828"},{"key":"e_1_3_2_216_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0010"},{"key":"e_1_3_2_217_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214561281"},{"key":"e_1_3_2_218_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509981"},{"key":"e_1_3_2_219_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.832.832"},{"key":"e_1_3_2_220_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-664086"},{"key":"e_1_3_2_221_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.203489"},{"key":"e_1_3_2_222_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236471"},{"key":"e_1_3_2_223_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595934"},{"key":"e_1_3_2_224_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2034"},{"key":"e_1_3_2_225_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_3_2_226_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-535047.The"},{"key":"e_1_3_2_227_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538546.There"},{"key":"e_1_3_2_228_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537555"},{"key":"e_1_3_2_229_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587279"},{"key":"e_1_3_2_230_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.802.802"},{"key":"e_1_3_2_231_1","first-page":"142","article-title":"A first-in-human trial of CUDC-907, an oral, first-in-classm dual inhibitor of PI3K and HDAC, in patients with relapsed\/refractory lymphoma and multiple myeloma.","volume":"33","author":"Bardeja JG","year":"2015","unstructured":"Bardeja JG, Oki Y, Patel MR, et\u00a0al. A first-in-human trial of CUDC-907, an oral, first-in-classm dual inhibitor of PI3K and HDAC, in patients with relapsed\/refractory lymphoma and multiple myeloma. J Clin Oncol 2015;33:142\u2013143.","journal-title":"J Clin Oncol"},{"key":"e_1_3_2_232_1","first-page":"8520","article-title":"Interim analysis of a phase I study of INCB040093, a PI3K{delta} inhibitor, alone or in combination with INCB039110, a selective JAK1 inhibitor, in patients (pts) with relapsed or refractory (r\/r) B-cell malignancies.","volume":"33","author":"Phillips TJ","year":"2015","unstructured":"Phillips TJ, Forero-Torres A, Sher T, et\u00a0al. Interim analysis of a phase I study of INCB040093, a PI3K{delta} inhibitor, alone or in combination with INCB039110, a selective JAK1 inhibitor, in patients (pts) with relapsed or refractory (r\/r) B-cell malignancies. ASCO Meeting Abstracts. 2015;33:8520.","journal-title":"ASCO Meeting Abstracts"},{"key":"e_1_3_2_233_1","first-page":"119","article-title":"TGR-1202, a novel once daily PI3K\u03b4 inhibitor, demonstrates clinical activity with a favorable safety profile lacking hepatotoxicity in patients with CLL and B-cell lymphoma.","volume":"33","author":"Burris HA","year":"2015","unstructured":"Burris HA, Patel M, Fenske T, et\u00a0al. TGR-1202, a novel once daily PI3K\u03b4 inhibitor, demonstrates clinical activity with a favorable safety profile lacking hepatotoxicity in patients with CLL and B-cell lymphoma. Hematol Oncol. 2015;33:119\u2013120.","journal-title":"Hematol Oncol"},{"key":"e_1_3_2_234_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.678.678"},{"key":"e_1_3_2_235_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.824080"},{"key":"e_1_3_2_236_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0770"},{"key":"e_1_3_2_237_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13603"},{"key":"e_1_3_2_238_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12845"},{"key":"e_1_3_2_239_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1028055"},{"key":"e_1_3_2_240_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1113280"},{"key":"e_1_3_2_241_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.60"},{"key":"e_1_3_2_242_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4"},{"key":"e_1_3_2_243_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-334904"},{"key":"e_1_3_2_244_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S70316"},{"key":"e_1_3_2_245_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506583"},{"key":"e_1_3_2_246_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-603100"},{"key":"e_1_3_2_247_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.391"},{"key":"e_1_3_2_248_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151074"},{"key":"e_1_3_2_249_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27863"},{"key":"e_1_3_2_250_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-139725"},{"key":"e_1_3_2_251_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.143"},{"key":"e_1_3_2_252_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13487"},{"key":"e_1_3_2_253_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"e_1_3_2_254_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.254.254"},{"key":"e_1_3_2_255_1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V124.21.1716.1716","article-title":"The BCL2 targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 is active in patients with relapsed or refractory non-Hodgkin\u2019s lymphoma.","volume":"124","author":"Harb WA","year":"2014","unstructured":"Harb WA, Lakhani N, Logsdon A, et\u00a0al. The BCL2 targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 is active in patients with relapsed or refractory non-Hodgkin\u2019s lymphoma. Blood. 2014;124:1716.","journal-title":"Blood"},{"key":"e_1_3_2_256_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08420.x"},{"key":"e_1_3_2_257_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168773"},{"key":"e_1_3_2_258_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.189"},{"key":"e_1_3_2_259_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0773"},{"key":"e_1_3_2_260_1","first-page":"179","article-title":"Phase I study of E7438 (EPZ-6438), an enhancer of Zeste-homolog 2 (EZH2) inhibitor: dose determination and preliminary activity in non-Hodgkin lymphoma.","author":"Ribrag V","year":"2015","unstructured":"Ribrag V, Soria J, Reyderman L, et\u00a0al. Phase I study of E7438 (EPZ-6438), an enhancer of Zeste-homolog 2 (EZH2) inhibitor: dose determination and preliminary activity in non-Hodgkin lymphoma. Hematol Oncol. 2015;179.","journal-title":"Hematol Oncol"},{"key":"e_1_3_2_261_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129395"},{"key":"e_1_3_2_262_1","doi-asserted-by":"publisher","DOI":"10.1159\/000315736"},{"key":"e_1_3_2_263_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412096"},{"key":"e_1_3_2_264_1","first-page":"2271","article-title":"Bortezomib-based therapy for mantle-cell lymphoma.","volume":"372","author":"Cavalli F.","year":"2015","unstructured":"Cavalli F. Bortezomib-based therapy for mantle-cell lymphoma. N Engl J Med. 2015;372:2271.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_265_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29502"},{"key":"e_1_3_2_266_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-566273"},{"key":"e_1_3_2_267_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1075019"},{"key":"e_1_3_2_268_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1014368"},{"key":"e_1_3_2_269_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.565"},{"key":"e_1_3_2_270_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4701"},{"key":"e_1_3_2_271_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4212"},{"key":"e_1_3_2_272_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.286"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2016.1173212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2016.1173212","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2016.1173212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:24:05Z","timestamp":1793406245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2016.1173212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":271,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,1]]}},"alternative-id":["10.3109\/10428194.2016.1173212"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2016.1173212","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}